$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
Patient Satisfaction Score
99%Client Satisfaction Score
Care teams stay with patients after discharge and in between office visits with easy-to-use platform that provides personalized treatment plans for immediate medical needs and chronic conditions.
Providers +
Pharmaceutical Companies +
Payers+